Balancing innovation, 'Ordre Public' and morality in human germline editing : a call for more nuanced approaches in patent law

, &
In Santa Slokenberga, Timo Minssen & Ana Nordberg (eds.), Governing, protecting, and regulating the future of genome editing: the significance of ELSPI perspectives. Boston: Brill/Nijhoff (2023)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,475

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

The Duty to Edit the Human Germline.Parker Crutchfield - 2022 - Res Publica 29 (3):347-365.
Budgets versus Bans: How U.S. Law Restricts Germline Gene Editing.Josephine Johnston - 2020 - Hastings Center Report 50 (2):4-5.
“Involuntary (Moral) Bioenhancement” Can Add Value to the Debate on Human Germline Genome Editing.Vojin Rakić - 2022 - American Journal of Bioethics 22 (9):54-56.
Ethics and patentability in biotechnology.Rafał Witek - 2005 - Science and Engineering Ethics 11 (1):105-111.
Why human germline genome editing is incompatible with equality in an inclusive society.Calum MacKellar - 2021 - The New Bioethics 27 (1):19-29.
Intergenerational monitoring in clinical trials of germline gene editing.Bryan Cwik - 2020 - Journal of Medical Ethics 46 (3):183-187.
Human Germline CRISPR-Cas Modification: Toward a Regulatory Framework.Niklaus H. Evitt, Shamik Mascharak & Russ B. Altman - 2015 - American Journal of Bioethics 15 (12):25-29.
Germline edits: Trust ethics review process.Julian Savulescu, Chris Gyngell & Thomas Douglas - 2015 - Nature 520.
Does human genome editing reinforce or violate human dignity?Seppe Segers & Heidi Mertes - 2019 - Bioethics 34 (1):33-40.
Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.Sebastian Schleidgen, Hans-Georg Dederer, Susan Sgodda, Stefan Cravcisin, Luca Lüneburg, Tobias Cantz & Thomas Heinemann - 2020 - BMC Medical Ethics 21 (1):1-12.
Nurturing or Purifying the Human Genome: Promises and Pitfalls of CRISPR Germline Editing.Evelyne Shuster - 2015 - Ethics in Biology, Engineering and Medicine 6 (3-4):299-304.
Public views on gene editing and its uses.Hub Zwart, George Gaskell & Imre Bard - 2017 - Nature Biotechnology 35 (11):121-123.
Prospects of Human Germline Modification by CRISPR-Cas9 – an Ethicist’s View.Dieter Birnbacher - 2018 - In Matthias Braun, Hannah Schickl & Peter Dabrock (eds.), Between Moral Hazard and Legal Uncertainty: Ethical, Legal and Societal Challenges of Human Genome Editing. Wiesbaden: Springer Fachmedien Wiesbaden. pp. 53-66.
The Virtues and Vices of Germline Editing Research.Cheryl Abbate - forthcoming - In Book Chapter.
Germline genome editing versus preimplantation genetic diagnosis: Is there a case in favour of germline interventions?Robert Ranisch - 2019 - Bioethics 34 (1):60-69.

Analytics

Added to PP
2022-11-19

Downloads
0

6 months
0

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references